Table 1.
Variables | MMT Group (n = 136) | BMT Group (n =16) | |||||
---|---|---|---|---|---|---|---|
| |||||||
n | Mean | SD | N | Mean | SD | P | |
Maternal Dose (mg) on Admission* | 136 | 131.3 | 69.9 | 16 | 18.6 | 14.3 | ----- |
Maternal Age in Years | 135 | 25.4 | 4.0 | 16 | 24.4 | 3.5 | 0.30 |
Gravidity with Current Pregnancy | 135 | 3.2 | 2.4 | 16 | 2.8 | 1.8 | 0.44 |
Parity Prior to Delivery | 134 | 2.5 | 0.99 | 16 | 1.8 | 0.98 | 0.15 |
GA When Prenatal Care Started in Weeks | 113 | 13.5 | 6.9 | 10 | 14.2 | 9.2 | 0.79 |
Number of Prenatal Visits Attended | 6 | 7.2 | 4.1 | 1 | 13 | 0.24 | |
Reported Use of Tobacco: | 131 (97%) | 15(93.8%) | 0.76 | ||||
None | 22 (16.8%) | 3 (20.0%) | |||||
0–1/2 PPD | 47 (35.9%) | 6 (40.0%) | |||||
1/2 PPD-1 PPD | 38 (29.0%) | 4 (26.7%) | |||||
>1 PPD | 24 (18.3%) | 2 (13.3%) | |||||
Reported Use of Alcohol | 10 (8.3%) | 1 (9.1%) | 0.89 | ||||
Use of SSRIs | 13 (10.1%) | 1 (8.3%) | 0.67 | ||||
Use of Benzodiazepines (prescribed or illicit) | 21 (16.2%) | 2 (16.7%) | 0.76 | ||||
Use of Marijuana | 50 (42.7%) | 2 (18.2%) | 0.05 | ||||
Use of Other Opioids | 128 (94%) | 14 (93%) | 0.31 |
GA = gestational age; PPD = pack per day; SSRIs = selective serotonin reuptake inhibitors. Parametric variables (age, gravida, parity, prenatal visit measures) were analyzed with independent sample t-tests; X2 was used for the remaining variables.
dose is not comparable between methadone and buprenorphine so is not statistically compared.